Article Information
History
- May 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Flávia M. Sant’Anna1,2,#,
- Mariana Araújo-Pereira3,4,5,#,
- Carolina A. S. Schmaltz2,#,
- María B. Arriaga3,4,5,#,
- Bruno B. Andrade3,4,5,6,7,* and
- Valeria C. Rolla1,2
- 1Postgraduate Program Clinical Research in Infectious Diseases, National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
- 2Clinical Research Laboratory on Mycobacteria, (LAPCLIN-TB), National Institute of Infectious Diseases Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil
- 3School of Medicine, Federal University of Bahia, Salvador, Brazil
- 4Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
- 5Laboratory of Inflammation and Biomarkers, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil
- 6Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil
- 7Curso de Medicina, Universidade Salvador (UNIFACS), Laureate Universities, Salvador, Brazil
- ↵*Correspondence:
Bruno B. Andrade, MD, PhD. Laboratory of Inflammation and Biomarkers, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Rua Waldemar Falcao, 121, Candeal, Salvador, Bahia 40296-710, Brazil. E-mail: Bruno.andrade{at}fiocruz.br.
↵# Flávia M. Sant’Anna, Mariana Araújo-Pereira, Carolina A. S. Schmaltz and María B. Arriaga equally contributed to the work.
* The senior authors Bruno B. Andrade and Valeria C Rolla equally contributed to the work.
Posted May 31, 2022.
